Shu Qin

961 total citations
31 papers, 586 citations indexed

About

Shu Qin is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Shu Qin has authored 31 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Epidemiology. Recurrent topics in Shu Qin's work include Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Ophthalmology and Visual Impairment Studies (4 papers). Shu Qin is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Ophthalmology and Visual Impairment Studies (4 papers). Shu Qin collaborates with scholars based in China and United States. Shu Qin's co-authors include Xiaocheng Cheng, Lei Gao, Dongying Zhang, Linna You, Xuesong Wen, Dan Jiang, Guoqiang Cai, Xiao‐Wei Tan, Bin He and Lei Peng and has published in prestigious journals such as PLoS ONE, Mayo Clinic Proceedings and Medicine.

In The Last Decade

Shu Qin

30 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Qin China 12 287 185 118 84 77 31 586
Adem Atıcı Türkiye 15 397 1.4× 291 1.6× 156 1.3× 96 1.1× 52 0.7× 84 734
Peter Jirak Austria 15 337 1.2× 85 0.5× 64 0.5× 65 0.8× 83 1.1× 52 690
Deanna Gill United States 5 206 0.7× 316 1.7× 199 1.7× 68 0.8× 25 0.3× 11 498
Weiqin Lin Singapore 12 264 0.9× 81 0.4× 43 0.4× 40 0.5× 76 1.0× 57 531
Bili Zhang China 11 86 0.3× 116 0.6× 60 0.5× 59 0.7× 64 0.8× 45 486
Luca Bergamaschi Italy 15 489 1.7× 160 0.9× 94 0.8× 63 0.8× 42 0.5× 58 838
Hanna Bräuninger Germany 6 235 0.8× 440 2.4× 281 2.4× 79 0.9× 21 0.3× 8 652
С.Т. Мацкеплишвили Russia 11 193 0.7× 113 0.6× 129 1.1× 20 0.2× 47 0.6× 67 446
Benjamin Garfield United Kingdom 12 87 0.3× 185 1.0× 124 1.1× 45 0.5× 257 3.3× 26 686
Isabel M McFarlane United States 12 119 0.4× 78 0.4× 70 0.6× 28 0.3× 58 0.8× 75 511

Countries citing papers authored by Shu Qin

Since Specialization
Citations

This map shows the geographic impact of Shu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Qin more than expected).

Fields of papers citing papers by Shu Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Qin. The network helps show where Shu Qin may publish in the future.

Co-authorship network of co-authors of Shu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Qin. A scholar is included among the top collaborators of Shu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Qin. Shu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qing, Baoqing Bai, Bo Tao, et al.. (2025). N-doped HOFs nanoenzymes enable dual-mode colorimetric/electrochemical aptasensing of AFB1. LWT. 233. 118466–118466. 1 indexed citations
2.
Jiang, Na, et al.. (2025). A survey of public eye-care behavior and myopia education. Frontiers in Public Health. 13. 1518956–1518956. 1 indexed citations
3.
Qin, Shu, et al.. (2025). The whole life cycle myopia management. Asia-Pacific Journal of Ophthalmology. 14(6). 100161–100161. 1 indexed citations
4.
Ye, Luyao, Shu Qin, Tao Yu, et al.. (2025). Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control. JAMA Ophthalmology. 143(9). 731–731.
6.
Liu, Jie, et al.. (2022). Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis. PLoS ONE. 17(2). e0263378–e0263378. 8 indexed citations
8.
Qin, Shu, et al.. (2021). Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis. Journal of Oncology Pharmacy Practice. 28(6). 1350–1356. 10 indexed citations
9.
Wen, Xuesong, Dan Jiang, Lei Gao, et al.. (2021). Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study. BMC Infectious Diseases. 21(1). 57–57. 24 indexed citations
10.
Cheng, Xiaocheng, Guoqiang Cai, Xuesong Wen, et al.. (2020). Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19. Aging. 12(23). 23436–23449. 8 indexed citations
11.
Gao, Lei, Liyou Wang, Zhiqiang Liu, et al.. (2020). TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways. Cell Death and Disease. 11(1). 44–44. 53 indexed citations
12.
Liu, Ling, et al.. (2020). TRPC6 participates in the development of blood pressure variability increase in sino-aortic denervated rats. Heart and Vessels. 35(12). 1755–1765. 5 indexed citations
13.
Cheng, Xiaocheng, Dongying Zhang, Suxin Luo, & Shu Qin. (2019). Effect of Catheter-Based Renal Denervation on Uncontrolled Hypertension: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 94(9). 1695–1706. 11 indexed citations
14.
Peng, Yan, Junjie Fang, Wei Huang, & Shu Qin. (2019). Efficacy of Cognitive Behavioral Therapy for Heart Failure. International Heart Journal. 60(3). 665–670. 20 indexed citations
15.
Xiang, Rui, et al.. (2019). Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling. Respiratory Research. 20(1). 121–121. 16 indexed citations
16.
Cheng, Xiaocheng, et al.. (2019). Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. EP Europace. 21(10). 1509–1518. 53 indexed citations
17.
Feng, Panpan, Yi Huang, Sihang Wang, et al.. (2018). Analysis of the Associations between Obesity Indices and Left Ventricular Mass. Cardiology. 141(4). 183–189. 7 indexed citations
18.
Cheng, Xiaocheng, et al.. (2018). Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Chronic Kidney Disease: A Meta-Analysis. Journal of Cardiothoracic and Vascular Anesthesia. 33(8). 2221–2230. 7 indexed citations
19.
Yang, Wei, Qi Hua, Yujie Zhou, et al.. (2015). A Multicenter, Randomized, Trial Comparing Urapidil and Nitroglycerin in Multifactor Heart Failure in the Elderly. The American Journal of the Medical Sciences. 350(2). 109–115. 9 indexed citations
20.
Xiao, Hua, et al.. (2010). TGF‐β1 Expression and Atrial Myocardium Fibrosis Increase in Atrial Fibrillation Secondary to Rheumatic Heart Disease. Clinical Cardiology. 33(3). 149–156. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026